Carlson Capital’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,000
| Closed | -$37.8K | – | 102 |
|
|
2024
Q1 | $37.8K | Sell |
20,000
-100,000
| -83% | -$189K | ﹤0.01% | 109 |
|
|
2023
Q4 | $317K | Sell |
120,000
-15,000
| -11% | -$39.6K | 0.03% | 114 |
|
|
2023
Q3 | $311K | Buy |
135,000
+964
| +0.7% | +$2.22K | 0.02% | 125 |
|
|
2023
Q2 | $489K | Sell |
134,036
-120,000
| -47% | -$438K | 0.04% | 110 |
|
|
2023
Q1 | $907K | Sell |
254,036
-110,964
| -30% | -$396K | 0.09% | 99 |
|
|
2022
Q4 | $1.04M | Sell |
365,000
-170,000
| -32% | -$485K | 0.08% | 103 |
|
|
2022
Q3 | $1.19M | Sell |
535,000
-45,000
| -8% | -$100K | 0.09% | 100 |
|
|
2022
Q2 | $1.44M | Buy |
580,000
+175,000
| +43% | +$436K | 0.1% | 106 |
|
|
2022
Q1 | $1.98M | Buy |
405,000
+215,000
| +113% | +$1.05M | 0.14% | 123 |
|
|
2021
Q4 | $2.15M | Buy |
190,000
+87,184
| +85% | +$986K | 0.12% | 114 |
|
|
2021
Q3 | $1.5M | Sell |
102,816
-47,884
| -32% | -$698K | 0.08% | 142 |
|
|
2021
Q2 | $1.76M | Sell |
150,700
-3,900
| -3% | -$45.4K | 0.08% | 133 |
|
|
2021
Q1 | $1.89M | Buy |
154,600
+69,600
| +82% | +$849K | 0.07% | 148 |
|
|
2020
Q4 | $1.06M | Buy |
+85,000
| New | +$1.06M | 0.04% | 143 |
|